Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literature.
about
Outcomes, costs and cost-effectiveness of treating hepatitis C with direct acting antivirals.Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases.Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence.Economic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection.Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C.
P2860
Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cost-effectiveness of protease ...... eview of published literature.
@en
type
label
Cost-effectiveness of protease ...... eview of published literature.
@en
prefLabel
Cost-effectiveness of protease ...... eview of published literature.
@en
P2093
P2860
P1476
Cost-effectiveness of protease ...... eview of published literature.
@en
P2093
Javier Mar
Ramón San Miguel
Vicente Gimeno-Ballester
P2860
P304
P356
10.1586/14737167.2014.906307
P577
2014-04-23T00:00:00Z